Department of Gastroenterology, The Second Affiliated Hospital, Xi'an Jiaotong University, Shaanxi, China.
Department of Gastroenterology, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.
Clin Transl Gastroenterol. 2020 Dec;11(12):e00278. doi: 10.14309/ctg.0000000000000278.
Although the Rome criteria were created primarily for research purposes, it was an important question whether the Rome criteria can distinguish organic dyspepsia from functional dyspepsia (FD). We evaluated the accuracy of the Rome IV criteria in identifying patients with FD and compared the differences between the Rome IV, Rome III, and potential Asia criteria in identifying patients with FD.
In this cross-sectional study, we analyzed data from patients who met the inclusion and exclusion criteria from March 2018 to January 2019 at 2 tertiary hospitals.
A total of 600 patients were enrolled in this study, including 381 individuals met the Rome IV criteria for FD, 438 individuals met the Rome III criteria for FD, and 525 individuals met the potential Asia criteria for FD. The Rome IV criteria identified patients with FD with 67.3% sensitivity and 38.4% specificity, and the positive and negative likelihood ratios of FD identified by Rome IV criteria were 1.09 (95% confidence interval 0.97-1.24) and 0.85 (95% confidence interval 0.67-1.08), respectively. There was no significant difference in the area under Rome IV, Rome III, or potential Asia criteria receiver operating characteristic curves in identifying FD (P > 0.05).
The Rome IV criteria were no better than the Rome III or potential Asia criteria in identifying FD and were not helpful in identifying patients with FD. Hence, although the Rome criteria remain useful for defining patients with FD for inclusion into clinical treatment trials, they should not be used for diagnosing FD.
尽管罗马标准主要是为研究目的而制定的,但罗马标准能否区分器质性消化不良和功能性消化不良(FD)是一个重要问题。我们评估了罗马 IV 标准识别 FD 患者的准确性,并比较了罗马 IV、罗马 III 和潜在亚洲标准在识别 FD 患者方面的差异。
在这项横断面研究中,我们分析了 2018 年 3 月至 2019 年 1 月期间 2 家 3 级医院符合纳入和排除标准的患者数据。
共有 600 名患者纳入本研究,其中 381 名符合罗马 IV 标准的 FD 患者,438 名符合罗马 III 标准的 FD 患者,525 名符合潜在亚洲标准的 FD 患者。罗马 IV 标准对 FD 的诊断敏感度为 67.3%,特异度为 38.4%,罗马 IV 标准诊断 FD 的阳性和阴性似然比分别为 1.09(95%置信区间为 0.97-1.24)和 0.85(95%置信区间为 0.67-1.08)。在识别 FD 方面,罗马 IV、罗马 III 或潜在亚洲标准的曲线下面积无显著差异(P>0.05)。
罗马 IV 标准在识别 FD 方面并不优于罗马 III 或潜在亚洲标准,也无助于识别 FD 患者。因此,尽管罗马标准在将 FD 患者纳入临床治疗试验的定义方面仍然有用,但不应用于 FD 的诊断。